FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2364528891> ?p ?o ?g. }

• W2364528891 endingPage "37497" @default.
• W2364528891 startingPage "37487" @default.
• W2364528891 abstract "// Valli De Re 1,* , Mariangela De Zorzi 1,* , Laura Caggiari 1 , Gianfranco Lauletta 2 , Maria Lina Tornesello 3 , Elisa Fognani 4 , Marta Miorin 5 , Vito Racanelli 6 , Luca Quartuccio 7 , Laura Gragnani 4 , Sabino Russi 2 , Fabio Pavone 2 , Michela Ghersetti 8 , Elena Garlatti Costa 8 , Pietro Casarin 8 , Riccardo Bomben 9 , Cesare Mazzaro 9 , Giancarlo Basaglia 10 , Massimiliano Berretta 11 , Emanuela Vaccher 11 , Francesco Izzo 12 , Franco Maria Buonaguro 3 , Salvatore De Vita 7 , Anna Linda Zignego 4 , Paolo De Paoli 13 and Riccardo Dolcetti 14,15 1 Bio-Proteomics Facility/ Cancer Bioimmunotherapy, Department of Translational Research, Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy 2 Liver Unit, Division of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari, Italy 3 Molecular Biology and Viral Oncology Unit, Istituto Nazionale Tumori “Fondazione G. Pascale” - IRCCS, Napoli, Italy 4 Interdepartmental Center for Systemic Manifestations of Hepatitis Virus MASVE, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy 5 Cytogenetics and Molecular Biology Unit, Santa Maria degli Angeli Hospital Pordenone, Pordenone, Italy 6 Immunology Section, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari, Italy 7 Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”, Udine, Italy 8 Internal Medicine-Liver Unit, Santa Maria degli Angeli Hospital Pordenone, Pordenone, Italy 9 Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy 10 Microbiology-Immunology and Virology Unit, Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy 11 Medical Oncology, Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy 12 Hepatobiliary Unit, Istituto Nazionale Tumori “Fondazione G. Pascale” - IRCCS, Napoli, Italy 13 Scientific Directorate, Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy 14 Cancer Bio-Immunotherapy, Department of Translational Research, Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy 15 University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Queensland, Australia * These authors have equally contributed to this study as first authors Correspondence to: Valli De Re, email: // Keywords : HCV, TLR2, IL28B, HCC, NHL, Immunology and Microbiology Section, Immune response, Immunity Received : February 12, 2016 Accepted : April 19, 2016 Published : May 11, 2016 Abstract To explore the relationship between innate immunity and hepatitis C Virus (HCV) in determining the risk of cirrhosis (CIR), hepatocellular carcinoma (HCC), mixed cryoglobulinemia syndrome (MCS) and non-Hodgkin lymphoma (NHL), we investigated the impact of the toll-like receptor-2 (TLR2) and interleukin-28B (IL28B) genetic variants. TLR2 -174 del variant was associated with TLR2 expression and with specific downstream molecules that drive the expression of different interleukins; rs12979860 Il28B was important in response to interferon-treatment and in spontaneous clearance of HCV. The risk for liver and lymphoproliferative diseases in HCV progression was clarified by stratifying 862 HCV-positive patients into groups based on liver (CIR, HCC) and lymphoproliferative HCV-related diseases (MCS, NHL) and compared with chronic HCV (CHC) infection. Analysis of TLR2-IL28B haplotypes showed an association of wild type haplotype with the lymphoproliferative diseases (OR 1.77, p = 0.029) and a slight increase in HCV viral load (HR 1.38, p = 0.054). Wild type haplotype (TLR2 ins/ins- IL28B C/C) was also found associated with older age in patients with an hepatic diseases (in CIR and in HCC p = 0.038 and p = 0.020, respectively) supporting an effect of innate immunity in the liver disease progression. TLR2 and IL28B polymorphisms in combination showed a role in the control of HCV viral load and different HCV disease progression." @default.
• W2364528891 created "2016-06-24" @default.
• W2364528891 creator A5000434082 @default.
• W2364528891 creator A5011114134 @default.
• W2364528891 creator A5012096745 @default.
• W2364528891 creator A5013492063 @default.
• W2364528891 creator A5016453181 @default.
• W2364528891 creator A5021793394 @default.
• W2364528891 creator A5022015646 @default.
• W2364528891 creator A5022557606 @default.
• W2364528891 creator A5027662125 @default.
• W2364528891 creator A5027726048 @default.
• W2364528891 creator A5029336619 @default.
• W2364528891 creator A5029966387 @default.
• W2364528891 creator A5048428887 @default.
• W2364528891 creator A5050032872 @default.
• W2364528891 creator A5050946484 @default.
• W2364528891 creator A5062904109 @default.
• W2364528891 creator A5064993921 @default.
• W2364528891 creator A5065701928 @default.
• W2364528891 creator A5066185290 @default.
• W2364528891 creator A5071674836 @default.
• W2364528891 creator A5072784690 @default.
• W2364528891 creator A5081634636 @default.
• W2364528891 creator A5085916135 @default.
• W2364528891 creator A5087387309 @default.
• W2364528891 creator A5091003529 @default.
• W2364528891 creator A5091091710 @default.
• W2364528891 date "2016-05-11" @default.
• W2364528891 modified "2023-09-23" @default.
• W2364528891 title "HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2" @default.
• W2364528891 cites W1202734720 @default.
• W2364528891 cites W1483063718 @default.
• W2364528891 cites W1517161840 @default.
• W2364528891 cites W1964790913 @default.
• W2364528891 cites W1981779827 @default.
• W2364528891 cites W1998637232 @default.
• W2364528891 cites W2008797060 @default.
• W2364528891 cites W2013202475 @default.
• W2364528891 cites W2013314533 @default.
• W2364528891 cites W2013721785 @default.
• W2364528891 cites W2021487557 @default.
• W2364528891 cites W2022345455 @default.
• W2364528891 cites W2022687771 @default.
• W2364528891 cites W2022915690 @default.
• W2364528891 cites W2031842797 @default.
• W2364528891 cites W2034275921 @default.
• W2364528891 cites W2036990065 @default.
• W2364528891 cites W2046735295 @default.
• W2364528891 cites W2047872502 @default.
• W2364528891 cites W2063285149 @default.
• W2364528891 cites W2071696199 @default.
• W2364528891 cites W2075681199 @default.
• W2364528891 cites W2086409213 @default.
• W2364528891 cites W2093977114 @default.
• W2364528891 cites W2095004085 @default.
• W2364528891 cites W2107432272 @default.
• W2364528891 cites W2111637529 @default.
• W2364528891 cites W2128469527 @default.
• W2364528891 cites W2138860727 @default.
• W2364528891 cites W2145146728 @default.
• W2364528891 cites W2147248710 @default.
• W2364528891 cites W2148302916 @default.
• W2364528891 cites W2152543398 @default.
• W2364528891 cites W2156236127 @default.
• W2364528891 cites W2157268533 @default.
• W2364528891 cites W2164157473 @default.
• W2364528891 cites W2166682916 @default.
• W2364528891 cites W2264237902 @default.
• W2364528891 cites W2397947765 @default.
• W2364528891 cites W43722475 @default.
• W2364528891 doi "https://doi.org/10.18632/oncotarget.9303" @default.
• W2364528891 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5122326" @default.
• W2364528891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27183918" @default.
• W2364528891 hasPublicationYear "2016" @default.
• W2364528891 type Work @default.
• W2364528891 sameAs 2364528891 @default.
• W2364528891 citedByCount "17" @default.
• W2364528891 countsByYear W23645288912016 @default.
• W2364528891 countsByYear W23645288912017 @default.
• W2364528891 countsByYear W23645288912018 @default.
• W2364528891 countsByYear W23645288912019 @default.
• W2364528891 countsByYear W23645288912020 @default.
• W2364528891 countsByYear W23645288912021 @default.
• W2364528891 countsByYear W23645288912022 @default.
• W2364528891 countsByYear W23645288912023 @default.
• W2364528891 crossrefType "journal-article" @default.
• W2364528891 hasAuthorship W2364528891A5000434082 @default.
• W2364528891 hasAuthorship W2364528891A5011114134 @default.
• W2364528891 hasAuthorship W2364528891A5012096745 @default.
• W2364528891 hasAuthorship W2364528891A5013492063 @default.
• W2364528891 hasAuthorship W2364528891A5016453181 @default.
• W2364528891 hasAuthorship W2364528891A5021793394 @default.
• W2364528891 hasAuthorship W2364528891A5022015646 @default.
• W2364528891 hasAuthorship W2364528891A5022557606 @default.
• W2364528891 hasAuthorship W2364528891A5027662125 @default.
• W2364528891 hasAuthorship W2364528891A5027726048 @default.
• W2364528891 hasAuthorship W2364528891A5029336619 @default.

• next